BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21045148)

  • 1. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.
    Mandal PK; Schneider M; Kölle P; Kuhlencordt P; Förster H; Beck H; Bornkamm GW; Conrad M
    Cancer Res; 2010 Nov; 70(22):9505-14. PubMed ID: 21045148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.
    Prigge JR; Eriksson S; Iverson SV; Meade TA; Capecchi MR; Arnér ES; Schmidt EE
    Free Radic Biol Med; 2012 Feb; 52(4):803-10. PubMed ID: 22198266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification.
    Iverson SV; Eriksson S; Xu J; Prigge JR; Talago EA; Meade TA; Meade ES; Capecchi MR; Arnér ES; Schmidt EE
    Free Radic Biol Med; 2013 Oct; 63():369-80. PubMed ID: 23743293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylglyoxal, the foe and friend of glyoxalase and Trx/TrxR systems in HT22 nerve cells.
    Dafre AL; Goldberg J; Wang T; Spiegel DA; Maher P
    Free Radic Biol Med; 2015 Dec; 89():8-19. PubMed ID: 26165190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.
    Wall SB; Wood R; Dunigan K; Li Q; Li R; Rogers LK; Tipple TE
    Oxid Med Cell Longev; 2019; 2019():7945983. PubMed ID: 30805084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
    Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
    Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KEAP1-dependent synthetic lethality induced by AKT and TXNRD1 inhibitors in lung cancer.
    Dai B; Yoo SY; Bartholomeusz G; Graham RA; Majidi M; Yan S; Meng J; Ji L; Coombes K; Minna JD; Fang B; Roth JA
    Cancer Res; 2013 Sep; 73(17):5532-43. PubMed ID: 23824739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes impairs exercise training-associated thioredoxin response and glutathione status in rat brain.
    Lappalainen Z; Lappalainen J; Oksala NK; Laaksonen DE; Khanna S; Sen CK; Atalay M
    J Appl Physiol (1985); 2009 Feb; 106(2):461-7. PubMed ID: 19074570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase.
    Malin D; Lee Y; Chepikova O; Strekalova E; Carlson A; Cryns VL
    Breast Cancer Res Treat; 2021 Dec; 190(3):373-387. PubMed ID: 34553295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration.
    Rollins MF; van der Heide DM; Weisend CM; Kundert JA; Comstock KM; Suvorova ES; Capecchi MR; Merrill GF; Schmidt EE
    J Cell Sci; 2010 Jul; 123(Pt 14):2402-12. PubMed ID: 20571049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of hyperoxia-induced growth inhibition in H441 cells by gene transfer of mitochondrially targeted glutathione reductase.
    O'Donovan DJ; Katkin JP; Tamura T; Smith CV; Welty SE
    Am J Respir Cell Mol Biol; 2000 Jun; 22(6):732-8. PubMed ID: 10837371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase.
    Prigge JR; Coppo L; Martin SS; Ogata F; Miller CG; Bruschwein MD; Orlicky DJ; Shearn CT; Kundert JA; Lytchier J; Herr AE; Mattsson Å; Taylor MP; Gustafsson TN; Arnér ESJ; Holmgren A; Schmidt EE
    Cell Rep; 2017 Jun; 19(13):2771-2781. PubMed ID: 28658624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase.
    Li J; Zuo X; Cheng P; Ren X; Sun S; Xu J; Holmgren A; Lu J
    Metallomics; 2019 Sep; 11(9):1490-1497. PubMed ID: 31359011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of thioredoxin and its reductase attenuates arsenic trioxide‑induced growth suppression in human pulmonary artery smooth muscle cells by reducing oxidative stress.
    Park WH
    Oncol Rep; 2020 Jan; 43(1):358-367. PubMed ID: 31789420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development.
    Jakupoglu C; Przemeck GK; Schneider M; Moreno SG; Mayr N; Hatzopoulos AK; de Angelis MH; Wurst W; Bornkamm GW; Brielmeier M; Conrad M
    Mol Cell Biol; 2005 Mar; 25(5):1980-8. PubMed ID: 15713651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thioredoxin reductase-1 deletion on embryogenesis and transcriptome.
    Bondareva AA; Capecchi MR; Iverson SV; Li Y; Lopez NI; Lucas O; Merrill GF; Prigge JR; Siders AM; Wakamiya M; Wallin SL; Schmidt EE
    Free Radic Biol Med; 2007 Sep; 43(6):911-23. PubMed ID: 17697936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages.
    Staples S; Wall SB; Li R; Tipple TE
    Life Sci; 2020 Oct; 259():118285. PubMed ID: 32798556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel persulfide detection method reveals protein persulfide- and polysulfide-reducing functions of thioredoxin and glutathione systems.
    Dóka É; Pader I; Bíró A; Johansson K; Cheng Q; Ballagó K; Prigge JR; Pastor-Flores D; Dick TP; Schmidt EE; Arnér ES; Nagy P
    Sci Adv; 2016 Jan; 2(1):e1500968. PubMed ID: 26844296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
    Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
    Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.